Albumin fusion proteins
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 3, 2015
Grant Date -
May 2, 2013
app pub date -
Oct 16, 2012
filing date -
Jun 7, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
First Claim
Other Claims data not available
Family
International Classification(s)
- 2012 Application Filing Year
- C07H Class
- 1452 Applications Filed
- 1128 Patents Issued To-Date
- 77.69 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 16 Citation Count
- C07H Class
- 90.56 % this patent is cited more than
- 10 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Sep 3, 2026 |
